Andrew Fisher is General Counsel of Verona Pharma plc. Currently has a direct ownership of 300,000 shares of VRNA, which is worth approximately $11.4 Million. The most recent transaction as insider was on Oct 30, 2024, when has been sold 300,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 300K
n/a 3M change
n/a 12M change
Total Value Held $11.4 Million

Andrew Fisher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 30 2024
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Ordinary Shares
AF

Andrew Fisher

General Counsel
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA